Patent · US Active

Oral drug composition and use thereof

US11278630B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2020
Grant dateMar 22, 2022
Priority date
Expiry dateMay 23, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides an oral drug composition including a prodrug and a carrier. The prodrug bonds an active drug to a spacer with a covalent bond, in which the spacer has a disulfide bond. The carrier is for carrying the prodrug with an efficient amount, and the carrier includes a β-1,3-D-glucan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.